PDB Short entry for 2VXD HEADER NUCLEAR PROTEIN 03-JUL-08 2VXD TITLE THE STRUCTURE OF THE C-TERMINAL DOMAIN OF NUCLEOPHOSMIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEOPHOSMIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, RESIDUES 214-265; COMPND 5 SYNONYM: NPM, NUCLEOLAR PHOSPHOPROTEIN B23, NUMATRIN, NUCLEOLAR COMPND 6 PROTEIN NO38; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CHROMOSOMAL REARRANGEMENT, NUCLEAR PROTEIN, PROTO-ONCOGENE, KEYWDS 2 PHOSPHOPROTEIN, ALTERNATIVE SPLICING, AML, NUCLEUS, NUCLEOLUS, RNA- KEYWDS 3 BINDING, ACETYLATION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.BYCROFT,C.G.GRUMMITT REVDAT 5 23-JUN-21 2VXD 1 REMARK REVDAT 4 24-JUL-13 2VXD 1 REMARK VERSN DBREF SEQADV REVDAT 4 2 1 SCALE1 SCALE2 REVDAT 3 24-FEB-09 2VXD 1 VERSN REVDAT 2 26-AUG-08 2VXD 1 JRNL REVDAT 1 15-JUL-08 2VXD 0 JRNL AUTH C.G.GRUMMITT,F.M.TOWNSLEY,C.M.JOHNSON,A.J.WARREN,M.BYCROFT JRNL TITL STRUCTURAL CONSEQUENCES OF NUCLEOPHOSMIN MUTATIONS IN ACUTE JRNL TITL 2 MYELOID LEUKEMIA. JRNL REF J.BIOL.CHEM. V. 283 23326 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18511415 JRNL DOI 10.1074/JBC.M801706200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 JRNL CITATION ABOVE REMARK 4 REMARK 4 2VXD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-JUL-08. REMARK 100 THE DEPOSITION ID IS D_1290036662. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.0 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 150 REMARK 210 PRESSURE : 1.0 ATM REMARK 210 SAMPLE CONTENTS : 10% WATER/90% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 700 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; AVANCE II REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 150 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : LEAST RESTRAINT VIOLATION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NONE REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 3 -169.55 66.13 REMARK 500 1 MET A 38 73.35 -69.72 REMARK 500 3 SER A 20 -34.83 -178.31 REMARK 500 3 LEU A 21 146.02 74.23 REMARK 500 3 PRO A 22 171.51 -56.43 REMARK 500 4 PRO A 22 170.46 -52.68 REMARK 500 6 ARG A 37 19.98 59.39 REMARK 500 7 SER A 20 113.50 -173.02 REMARK 500 8 PRO A 22 174.72 -53.36 REMARK 500 11 MET A 38 93.28 -56.62 REMARK 500 12 SER A 20 -36.53 -178.98 REMARK 500 12 LEU A 21 140.65 66.34 REMARK 500 12 MET A 38 72.89 -68.58 REMARK 500 13 MET A 38 88.56 -66.57 REMARK 500 14 PRO A 22 170.26 -54.44 REMARK 500 17 MET A 38 79.45 -68.45 REMARK 500 18 SER A 3 126.92 63.53 REMARK 500 18 PRO A 22 176.58 -58.35 REMARK 500 19 SER A 20 -35.72 179.39 REMARK 500 19 LEU A 21 151.56 65.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 TWO EXTRA GLYCINE RESIDUES AT THE N-TERMINUS DBREF 2VXD A 3 54 UNP P06748 NPM_HUMAN 214 265 SEQADV 2VXD GLY A 1 UNP P06748 EXPRESSION TAG SEQADV 2VXD GLY A 2 UNP P06748 EXPRESSION TAG SEQRES 1 A 54 GLY GLY SER VAL GLU ASP ILE LYS ALA LYS MET GLN ALA SEQRES 2 A 54 SER ILE GLU LYS GLY GLY SER LEU PRO LYS VAL GLU ALA SEQRES 3 A 54 LYS PHE ILE ASN TYR VAL LYS ASN CYS PHE ARG MET THR SEQRES 4 A 54 ASP GLN GLU ALA ILE GLN ASP LEU TRP GLN TRP ARG LYS SEQRES 5 A 54 SER LEU HELIX 1 1 GLY A 2 LYS A 17 1 16 HELIX 2 2 VAL A 24 ARG A 37 1 14 HELIX 3 3 ASP A 40 LEU A 54 1 15 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000